Join forces with MinuteMed and Planet Nutrition for a hassle-free, personalized weight loss journey
RV-8451, differentiated oral, muscle-preserving GLP-1 candidate for obesity Recent Highlights: In February 2026, Rivus stated it was entering a pivotal year, advancing HU6 in the AMPLIFY Phase 2 MASH trial while preparing the first clinical trial for RV-8451, its muscle-preserving oral GLP-1 candidate, designed to address the muscle-loss criticism leveled at existing GLP-1 therapies
Practical checklist to start today 1
Please inform the nurse if you are on blood thinners or if you have any concerns
Before Bed : The most common timing for GHSs, as it synchronizes with the body's natural nocturnal GH pulse, maximizing the anabolic and restorative effects during sleep
Over-the-Counter Remedies : For some individuals, over-the-counter medications can provide relief